Shamburg News · 8-K filed Nov 13, 2026, 12:12 PM EST

Integrated BioPharma Reports Quarter Ended September 30, 2026 Revenue Decline and Net Loss

INBP · INTEGRATED BIOPHARMA INC

  • Earnings
  • Materiality: high

Integrated BioPharma, Inc. reported revenue of $9.9 million for the quarter ended September 30, 2026, a decrease of $2.8 million or approximately 22.0% from $12.7 million a year earlier. The company reported an operating loss of $1.0 million and a net loss of approximately $0.7 million, or $(0.02) per diluted share, compared with net income of approximately $0.1 million, or $0.00 per diluted share, in the prior-year quarter. The press release was furnished under Item 2.02 as Exhibit 99.1.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Item 2.02, accession 0001437749-26-036730.

Written from the filing by Shamburg Markets. Figures are as reported by the company.